Market Overview
Global Personal Use Defibrillator market size was valued at USD 349 million in 2024. The market is projected to reach USD 438 million by 2031, exhibiting a CAGR of 3.4% during the forecast period.
Personal use defibrillators are life-saving devices designed to deliver an electric shock to the heart, restoring normal rhythm during dangerous arrhythmias like ventricular tachycardia without a pulse or ventricular fibrillation. These conditions arise in the heart's lower chambers, the ventricles, and can lead to sudden cardiac arrest if untreated. Available in forms such as wearable cardioverter defibrillators and implantable cardioverter defibrillators (ICDs), they empower individuals, especially those at high risk, to manage cardiac health proactively outside clinical settings.
Market size
USD 349 million in 2024
2032 USD 438 million by 2031
of 3.4%
Implantable Cardioverter Defibrillator (ICD) Segment Dominates the Market Due to its Proven
Efficacy in Long-Term Arrhythmia Management
The Implantable Cardioverter Defibrillator (ICD) segment leads due to its ability to continuously monitor heart rhythms and deliver precise shocks when needed, making it ideal for high-risk patients requiring permanent solutions. These devices are surgically implanted and offer features like pacing capabilities and data logging for physician review, contributing to their widespread use. In contrast, wearable options provide temporary protection during high-risk periods. The market is segmented based on type into:
Wearable Cardioverter Defibrillator
Implantable Cardioverter Defibrillator (ICD)
By Application
Implantable Cardioverter Defibrillator (ICD) Segment Dominates the Market Due to its
Proven Efficacy in Long-Term Arrhythmia Management
The Implantable Cardioverter Defibrillator (ICD) segment leads due to its ability to continuously monitor heart rhythms and deliver precise shocks when needed, making it ideal for high-risk patients requiring permanent solutions. These devices are surgically implanted and offer features like pacing capabilities and data logging for physician review, contributing to their widespread use. In contrast, wearable options provide temporary protection during high-risk periods. The market is segmented based on type into:
Wearable Cardioverter Defibrillator
Portable Neuromonitoring Device Market
Implantable Cardioverter Defibrillator (ICD)
Our Key Players
Medtronic
Abbott
Boston Scientific
Philips Healthcare
Zoll Medical
Biotronik Se
Physio-Control International
https://www.24lifesciences.com
